Table 5.
Prognostic factor | Hazard ratio (95% CI) | p-valuea | p-valueb |
---|---|---|---|
Sex (M: F) | 2.65 (1.12-6.23) | 0.0258 | 0.0317 |
Driver gene (+ vs. -/unknown) |
0.41 (0.16-1.01) | 0.0531 | 0.0351 |
Stage 0-III/IV | 4.63 (1.76-12.19) | 0.0019 | 0.0024 |
Pathology (Adenocarcinoma vs. Squamous carcinoma) |
7.44 (0.98-56.46) | 0.0522 | 0.0394 |
(Squamous carcinoma vs. Small cell carcinoma) |
0.70 (0.20-2.47) | 0.5833 | 0.9567 |
(Adenocarcinoma vs. Small cell carcinoma) | 0.09 (0.027-0.28) | < 0.0001 | 0.0001 |
aLog-rank (Mantel-Cox) Test; bGehan-Breslow-Wilcoxon Test; CI, confidence interval